/Lists

Healthtech Late Stage Investors & VC Firms

494 firms in this list, with a median first check of $1M. 98 of them lead rounds. Generated from verified public data and updated continuously.

Sectoral Asset Management
MontrealSeries B–Late Stage
8 people
Agate Medical Investments LP
Tel-AvivGrowth–Late Stage
West Capital
AlpineSeries A–Late Stage
9 people
Indonesia Investment Authority
JakartaGrowth–Late Stage
4 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
8 people
Fengate Private Equity
TorontoGrowth–Late Stage
11 people
KIC Ventures
Fort LauderdaleGrowth–Late Stage
10 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Claremont Creek Ventures
OaklandSeed–Late Stage$500K – $3M
5 people
Vesalius Biocapital III Partners SàRL
ConternSeries B–Late Stage$10.8M
11 people
Oost NL
ApeldoornSeed–Late Stage$108K – $5.4M
2 people
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
7 people
Prospect Hill Growth Partners
WalthamGrowth–Late Stage
10 people
Unfold Ventures
WrocławPre-Seed–Late Stage$110K – $1.1M
7 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
Iconica Partners
Silicon ValleySeed–Late Stage
4 people
Bombora
SydneyGrowth–Late Stage
8 people
Kern Capital, LLC
LarkspurSeries A–Late Stage$5M – $15M
1 person
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
7 people
naturalX Health Ventures
KarlsruheSeed–Late Stage$3.2M – $5.4M
4 people
Quest for Growth
LeuvenGrowth–Late Stage
8 people
Vocap Investment Partners
AtlantaPre-Seed–Late Stage
8 people
Yukon Capital Partners
TokyoGrowth–Late Stage
5 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.